Search research articles
Contact Us
Filters
Showing results (51-60 of 174) with videos related to
Page
of 18
Sort By:
The Journal of Clinical Investigation
|
February 9, 2013
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E Bhola, Justin M Balko, Teresa C Dugger, et al.
Cancer Research
|
August 23, 2013
Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer
Justin M Balko, Luis J Schwarz, Neil E Bhola, et al.
Circulation Research
|
June 14, 2021
RNA-Sequencing Reveals a Distinct Transcriptomic Signature for Giant Cell Myocarditis and Identifies Novel Druggable Targets
Kaushik Amancherla, Juan Qin, Yu Wang, et al.
Translational Lung Cancer Research
|
March 10, 2023
Peripheral T-cell receptor repertoire dynamics in small cell lung cancer
Meridith L Balbach, Margaret L Axelrod, Justin M Balko, et al.
Journal for Immunotherapy of Cancer
|
March 15, 2020
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
Lihong Wang-Bishop, Mohamed Wehbe, Daniel Shae, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2019
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
Douglas B Johnson, Ali Manouchehri, Alexandra M Haugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2024
Associations of Immune Checkpoint Predictive Biomarkers (MHC-I and MHC-II) with Clinical and Molecular Features in a Diverse Breast Cancer Cohort
Xiaopeng Sun, Laura C Kennedy, Paula I Gonzalez-Ericsson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 15, 2020
Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration
Mohamed Wehbe, Lihong Wang-Bishop, Kyle W Becker, et al.
Molecular Cancer Therapeutics
|
August 11, 2012
Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplification
Justin M Balko, Ingrid A Mayer, Melinda E Sanders, et al.
International Journal of Oncology
|
December 5, 2025
[Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion
Jingchun Gao, Matthew J Mcconnell, Bin Yu, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 174) with videos related to
Sort By:
Page
of 18
The Journal of Clinical Investigation
|
February 9, 2013
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E Bhola, Justin M Balko, Teresa C Dugger, et al.
Cancer Research
|
August 23, 2013
Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer
Justin M Balko, Luis J Schwarz, Neil E Bhola, et al.
Circulation Research
|
June 14, 2021
RNA-Sequencing Reveals a Distinct Transcriptomic Signature for Giant Cell Myocarditis and Identifies Novel Druggable Targets
Kaushik Amancherla, Juan Qin, Yu Wang, et al.
Translational Lung Cancer Research
|
March 10, 2023
Peripheral T-cell receptor repertoire dynamics in small cell lung cancer
Meridith L Balbach, Margaret L Axelrod, Justin M Balko, et al.
Journal for Immunotherapy of Cancer
|
March 15, 2020
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
Lihong Wang-Bishop, Mohamed Wehbe, Daniel Shae, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2019
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
Douglas B Johnson, Ali Manouchehri, Alexandra M Haugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2024
Associations of Immune Checkpoint Predictive Biomarkers (MHC-I and MHC-II) with Clinical and Molecular Features in a Diverse Breast Cancer Cohort
Xiaopeng Sun, Laura C Kennedy, Paula I Gonzalez-Ericsson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 15, 2020
Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration
Mohamed Wehbe, Lihong Wang-Bishop, Kyle W Becker, et al.
Molecular Cancer Therapeutics
|
August 11, 2012
Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplification
Justin M Balko, Ingrid A Mayer, Melinda E Sanders, et al.
International Journal of Oncology
|
December 5, 2025
[Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion
Jingchun Gao, Matthew J Mcconnell, Bin Yu, et al.
Page
of 18